HAYWARD, Calif.--Soane BioSciences announced the appointment of Joseph Limber as president and CEO. Limber, who has 23 years pharmaceutical industry experience, was most recently president and CEO at Praecis Pharmaceuticals, a private company in Cambridge, Mass., that has discovered several novel drugs utilizing a proprietary high-throughput screening and optimization technology platform.
Prior to joining Praecis, Limber served as executive vice-president at Sequis Pharmaceuticals in Menlo Park, Calif., where he negotiated corporate partnerships worldwide and contributed to several public financings.
Soane applies advances in microfabrication and microfluidics to develop new tools for drug discovery and genomics. By performing integrated sample processing and analysis on microfluidic chips, these tools enable the rapid, parallel processing of large numbers of samples requiring only minute volumes of expensive or rare reagents.